Latest News- Phage Therapy Market: Escherichia coli is expected to lead the Product segment during 2024-2028

The Phage Therapy Market is being driven by Benefits of phage therapy over antibiotics

The Phage Therapy Market is expected to grow at a CAGR of 17.41% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 51 million. Phage therapy, an emerging approach to combat antibiotic-resistant bacteria, has garnered significant investment due to the escalating global health concern over antimicrobial resistance (AMR). In a recent development, AMR Action Fund and Deerfield Management committed an initial USD12 million, with an intended total investment of USD30 million, in Adaptive Phage's Series B1 round. This funding will support the clinical advancement of Adaptive Phage's pipeline of phage therapeutics, designed to treat AMR infections, addressing a pressing public health challenge. 

Get more information on Phage Therapy Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Escherichia coli
  • Staphylococcus aureus
  • Salmonella
  • Pseudomonas aeruginosa
  • Streptococcus
  • Klebsiella pneumoniae
  • Clostridium difficile
• Application
  • Animal health
  • Food industry
  • Human health
  • Aquaculture
  • Agriculture
  • Diagnostics
• By Route of Administration
  • Oral
  • Topical
  • Intravenous
  • Rectal
  • Others
• By Disease Indication
  • Urinary Tract Infections
  • Wound and Skin Infections
  • Gastrointestinal Infections
  • Respiratory Infections
  • Others
• Geography
  • Europe
    • UK
    • France
    • Netherlands
  • North America
    • Canada
    • US
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Benefits of phage therapy over antibiotics
• Increasing application of phage therapy for animal health
• Increasing application of phage therapy for human health

However, the market also witnesses some limitations, which are as follows:

• High quality and safety requirements for phage preparations
• Evolution of bacterial resistance to phages
• High regulatory control for phage therapy

Benefits of Buying Global Phage Therapy Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Phage Therapy Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Phage therapy encompasses various aspects, including the utilization of phage libraries, phage banks, and collections for the discovery of effective phages. Technologies such as phage sequencing, proteomics, metabolomics, transcriptomics, bioinformatics, modeling, simulation, prediction, design, optimization, and evolution are employed to enhance the understanding and application of phages. Phages exhibit specificity towards hosts and bacteria, leading to various mechanisms of killing, lysis, infection, replication, transduction, gene expression, and silencing, as well as biofilm formation and dispersal, biocontrol, bioremediation, bioprocessing, food safety, agriculture, pharmaceuticals, cosmetics, personal care, and veterinary medicine. Phage resistance and sensitivity are crucial factors in determining their efficacy.

Market Research Overview

The Phage Therapy Market is a significant segment of the global Pharmaceuticals Market, which encompasses entities involved in the research and development (R&D) or production of various pharmaceutical offerings, including generic and non-generic drugs, veterinary drugs, and now, phage cocktails as an alternative antibacterial therapy. The Phage Therapy Market's expansion is driven by the growing concern over antimicrobial resistance and the emergence of drug-resistant bacteria. Technavio, a leading global technology research agency, sizes the Healthcare Market based on the consolidated revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The Pharmaceuticals Market's growth is primarily influenced by demographic trends, such as the increasing global population aging, with the number of individuals over 60 years old predicted to rise significantly. Additionally, advancements in phage biocontrol, phage engineering, and phage genomics are expected to further fuel the Phage Therapy Market's growth.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/